1. Home
  2. PETS vs SAVA Comparison

PETS vs SAVA Comparison

Compare PETS & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PETS
  • SAVA
  • Stock Information
  • Founded
  • PETS 1996
  • SAVA 1998
  • Country
  • PETS United States
  • SAVA United States
  • Employees
  • PETS N/A
  • SAVA N/A
  • Industry
  • PETS Retail-Drug Stores and Proprietary Stores
  • SAVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PETS Consumer Staples
  • SAVA Health Care
  • Exchange
  • PETS Nasdaq
  • SAVA Nasdaq
  • Market Cap
  • PETS 118.8M
  • SAVA 134.2M
  • IPO Year
  • PETS N/A
  • SAVA N/A
  • Fundamental
  • Price
  • PETS $5.58
  • SAVA $2.55
  • Analyst Decision
  • PETS Sell
  • SAVA Buy
  • Analyst Count
  • PETS 2
  • SAVA 3
  • Target Price
  • PETS $3.50
  • SAVA $111.50
  • AVG Volume (30 Days)
  • PETS 296.2K
  • SAVA 12.4M
  • Earning Date
  • PETS 02-06-2025
  • SAVA 11-07-2024
  • Dividend Yield
  • PETS N/A
  • SAVA N/A
  • EPS Growth
  • PETS N/A
  • SAVA N/A
  • EPS
  • PETS N/A
  • SAVA N/A
  • Revenue
  • PETS $259,343,000.00
  • SAVA N/A
  • Revenue This Year
  • PETS N/A
  • SAVA N/A
  • Revenue Next Year
  • PETS $3.36
  • SAVA N/A
  • P/E Ratio
  • PETS N/A
  • SAVA N/A
  • Revenue Growth
  • PETS N/A
  • SAVA N/A
  • 52 Week Low
  • PETS $2.90
  • SAVA $2.55
  • 52 Week High
  • PETS $7.79
  • SAVA $42.20
  • Technical
  • Relative Strength Index (RSI)
  • PETS 56.24
  • SAVA 22.85
  • Support Level
  • PETS $5.41
  • SAVA $2.78
  • Resistance Level
  • PETS $6.85
  • SAVA $3.28
  • Average True Range (ATR)
  • PETS 0.45
  • SAVA 0.26
  • MACD
  • PETS -0.01
  • SAVA 0.25
  • Stochastic Oscillator
  • PETS 48.37
  • SAVA 0.00

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.

Share on Social Networks: